Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Brooks Life Science Systems Launch the Plate Auditor™ for Automated Compound Quality Control

Published: Tuesday, September 25, 2012
Last Updated: Tuesday, September 25, 2012
Bookmark and Share
The new Plate Auditor is the result of a successful collaboration with the Scripps Research Institute.

Brooks Life Science Systems, a division of Brooks Automation, Inc., announced the commercial launch of the Brooks Plate Auditor™, a fast, accurate and non-invasive tool for identification of precipitate and empty wells in compound and screening plates.

The new Plate Auditor is designed to evaluate the quality of microplate-based compound samples for precipitation and liquid volume prior to use in compound management and high throughput screening activities. The system rapidly analyzes plates to automatically verify sample integrity thus eliminating the need for extensive manual quality control.

“The contents of a plate are a fingerprint for all of the potential problems you encounter in a Compound Management operation; Plate Auditor allows easy and rapid detection of many of those problems using machine vision and sophisticated image processing”, stated Peter Hodder, PhD, Senior Director and Head of Lead Identification at the Florida campus of Scripps Research. The ability of the instrument to provide sample color information makes the Plate Auditor a unique option for monitoring sample quality over time, and identifying wells with artifacts which may interfere with or invalidate screening results.

Plate Auditor joins Celigo® Imaging Cytometer and Tube Auditor™ instruments as part of Brooks’ growing range of vision-based research instruments that analyze compounds, biological samples and adherent/non-adherent cells.

The Plate Auditor will be showcased at the MipTec Drug Discovery Conference, 24-27 September 2012, in Basel, Switzerland. Data highlighting how Plate Auditor enhances compound testing integrity was presented at the recent IQPC Compound Management and Integrity Conference, in Boston, MA, US.

In February 2012 Brooks announced the collaboration with the Scripps Research Institute to develop and commercialize the Plate Auditor instrument. “We are delighted to have worked with the Scripps Research Institute’s compound management group to bring the new Plate Auditor so rapidly to the market,” commented John Lillig, Senior Vice President and Managing Director of Brooks Life Science Systems.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Small Molecules Lead to a Big Change in Reaction Outcomes
Scientists have changed the behaviour of a group of molecules involved in carbon-oxygen bond synthesis.
Targeting Fat to Treat Cancer
Researchers develop novel cancer treatment that halts fat synthesis in cells, stunting tumors.
Hyperstable Peptides for 'On-Demand' Drugs
These small molecules can fold into different conformations that could allow for greater flexibility in precision drug design
Drug Leads Identified to Combat Heart Disease
Using three supercomputers, researchers surveyed protein structures through accelerated molecular dynamics.
Accelerating the Path to Molecules for Medicine
Researchers convert carbon-hydrogen bonds into nitriles - converting organic molecules into components of medicines.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos